Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Adaptive Biotechnologies Corporation (NASDAQ: ADPT)
ADPT Stock Predictions and Ratings
WSX Rating:
STRONG BUY
WSX Forecast (1yr):
15.10%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
23.50%
ADPT Stock Analysis
ADPT
PE Ratio:
ADPT
PEG Ratio:
Not Available
ADPT
Forward EPS Growth (12 month):
0.00%
ADPT
PS Ratio:
8.7
ADPT
PSG Ratio:
0.4
ADPT
Forward Revenue Growth (12 month):
22.70%
ADPT Articles
No data was found